216 related articles for article (PubMed ID: 30911800)
21. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.
Leppla SH
Proc Natl Acad Sci U S A; 1982 May; 79(10):3162-6. PubMed ID: 6285339
[TBL] [Abstract][Full Text] [Related]
22. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
[TBL] [Abstract][Full Text] [Related]
23. Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge.
Hutt JA; Lovchik JA; Drysdale M; Sherwood RL; Brasel T; Lipscomb MF; Lyons CR
Am J Pathol; 2014 Dec; 184(12):3205-16. PubMed ID: 25285720
[TBL] [Abstract][Full Text] [Related]
24. Structural Integrity of the Alveolar-Capillary Barrier in Cynomolgus Monkeys Challenged with Fully Virulent and Toxin-Deficient Strains of Bacillus anthracis.
D'Agnillo F; Zhang X; Williams MC
Am J Pathol; 2020 Oct; 190(10):2095-2110. PubMed ID: 32598882
[TBL] [Abstract][Full Text] [Related]
25. Anthrax edema toxin impairs clearance in mice.
Sastalla I; Tang S; Crown D; Liu S; Eckhaus MA; Hewlett IK; Leppla SH; Moayeri M
Infect Immun; 2012 Feb; 80(2):529-38. PubMed ID: 22104108
[TBL] [Abstract][Full Text] [Related]
26. Very Early Blood Diffusion of the Active Lethal and Edema Factors of Bacillus anthracis After Intranasal Infection.
Rougeaux C; Becher F; Goossens PL; Tournier JN
J Infect Dis; 2020 Feb; 221(4):660-667. PubMed ID: 31574153
[TBL] [Abstract][Full Text] [Related]
27. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
[TBL] [Abstract][Full Text] [Related]
28. Comparison of MALDI-TOF-MS and HPLC-ESI-MS/MS for endopeptidase activity-based quantification of Anthrax lethal factor in serum.
Kuklenyik Z; Boyer AE; Lins R; Quinn CP; Gallegos-Candela M; Woolfitt A; Pirkle JL; Barr JR
Anal Chem; 2011 Mar; 83(5):1760-5. PubMed ID: 21302970
[TBL] [Abstract][Full Text] [Related]
29. [Anthrax toxins].
Brossier F; Guidi-Rontani C; Mock M
C R Seances Soc Biol Fil; 1998; 192(3):437-44. PubMed ID: 9759382
[TBL] [Abstract][Full Text] [Related]
30. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
[TBL] [Abstract][Full Text] [Related]
31. [Molecular model of anthrax toxin translocation into target-cells].
Noskov AN
Bioorg Khim; 2014; 40(4):399-404. PubMed ID: 25898749
[TBL] [Abstract][Full Text] [Related]
32. Design and use of a novel substrate for simple, rapid, and specific early detection of anthrax infection.
Suryadi K; Shine N
PLoS One; 2018; 13(11):e0207084. PubMed ID: 30412638
[TBL] [Abstract][Full Text] [Related]
33. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
[TBL] [Abstract][Full Text] [Related]
34. Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen.
Zmuda JF; Zhang L; Richards T; Pham Q; Zukauskas D; Pierre JL; Laird MW; Askins J; Choi GH
J Immunol Methods; 2005 Mar; 298(1-2):47-60. PubMed ID: 15847796
[TBL] [Abstract][Full Text] [Related]
35. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
[TBL] [Abstract][Full Text] [Related]
36. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
[TBL] [Abstract][Full Text] [Related]
37. Anthrax Pathogenesis.
Moayeri M; Leppla SH; Vrentas C; Pomerantsev AP; Liu S
Annu Rev Microbiol; 2015; 69():185-208. PubMed ID: 26195305
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis for improved anthrax vaccines.
Brey RN
Adv Drug Deliv Rev; 2005 Jun; 57(9):1266-92. PubMed ID: 15935874
[TBL] [Abstract][Full Text] [Related]
39. Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin.
Vietri NJ; Tobery SA; Chabot DJ; Ingavale S; Somerville BC; Miller JA; Schellhase CW; Twenhafel NA; Fetterer DP; Cote CK; Klimko CP; Boyer AE; Woolfitt AR; Barr JR; Wright ME; Friedlander AM
J Infect Dis; 2021 Feb; 223(2):319-325. PubMed ID: 32697310
[TBL] [Abstract][Full Text] [Related]
40. Contribution of individual toxin components to virulence of Bacillus anthracis.
Pezard C; Berche P; Mock M
Infect Immun; 1991 Oct; 59(10):3472-7. PubMed ID: 1910002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
